A recent study reported that Gal-1 overexpression activated the FAK/PI3K/AKT pathway by upregulating expression of αvβ3 integrin, leading to enhanced HCC invasion via EMT and sorafenib resistance24. Here, AKT1 is linked to hepatocellular carcinoma.